• BECOME A MEMBER
  • MEMBER LOG IN
  • FIND A CLINIC
  • cs
    • en
    • es
    • fr
    • da
    • it
    • pl
    • nl
    • no
    • sv
    • ru
    • pt
    • de
  • Vote now
  • ABOUT HD
  • ABOUT EHDN
  • NEWS & EVENTS
  • HD Patients and Families
    • HD Patients and Families Home
    • Living with HD
    • Finding Clinics and Support
    • HD Research
  • HD Clinicians and Researchers
    • HD Clinicians and Researchers Home
    • Previous & Ongoing Research
    • Publications
    • EHDN Working Groups
    • Rater training and certification
    • Seed Fund Applications
    • Data-Mining Applications
    • Fellowship programme
    • Grant Management & Collaborations
  • Clinical Trial Sponsors
    • Clinical Trial Sponsors Home
    • Feasibility Assessment
    • Protocol Advice
    • Operational Support
    • Recruitment
    • Clinical Rater Training
    • HD Clinical Trial Site Certification Scheme
  • About Huntington's Disease
  • About EHDN
    • EHDN Structure
    • EHDN Working Groups
    • Grant Management & Collaborations
    • HD Clinics
    • Previous & Ongoing Research
    • Resources and Services
  • News & Events
  • REGISTRY LOGIN
  • MEMBER LOG IN
  • Find a Clinic
Skip to content
European Huntington's Disease Network
  • HD Patients and Families
    • Patients & Families Home
    • Living with HD
    • Finding Clinics and Support
    • HD Research
  • HD Clinicians and Researchers
    • Clinicians & Researchers Home
    • HD Science Think Tank
    • EHDN Working Groups
    • Fellowship programme
    • Seed Fund Applications
    • Grant management & Collaborations
    • Data-Mining Applications
    • Rater training and certification
    • Research & Publications
    • Guidelines
  • Clinical Trial Sponsors
    • Clinical Trial Sponsors Home
    • Protocol Advice
    • Feasibility Assessment
    • Operational Support
    • Recruitment
    • Clinical Rater Training
    • Site Certification Scheme

Roche global HD community letter – June 2018

Posted on Červen 8, 2018 Edited Červen 20, 2018 by Lisanne Muetze

June update from Roche: Getting to know Roche & Genentech, RG6042 (formerly known as IONIS-HTTRx)

Huntington’s disease development programme

Navigace pro příspěvek

EHDN2018 Plenary Meeting in Vienna – Join us!
Young HD researcher wins award

Subscribe to
EHDN news

* Denotes required field
  • © EHDN 2016
  • Terms of Use
  • Privacy Policy
  • Contact EHDN
  • University of Ulm
Twitter
LinkedIn